Reckitt’s Revenues Soar On Strength Of Adams Brands, Product Innovations
This article was originally published in The Tan Sheet
Executive Summary
Reckitt-Benckiser's revenues soared 13 percent in fiscal 2008 as health care and personal product sales grew more than twice as fast as its other segments - a trend the firm expects to continue despite private label competition and the global economic slump
You may also be interested in...
Perrigo Gains US Approval For OTC Guaifenesin/Pseudoephedrine Manufacturing
Predominant US OTC private label/store brand provider plans commercialize products in second half. Firm has yet to set date to release 2021 full-year and fourth-quarter results.
NACDS New Products In Brief
Reckitt doubles down with Mucinex
NACDS New Products In Brief
Reckitt doubles down with Mucinex